Does UPADACITINIB Cause Pulmonary embolism? 423 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 423 reports of Pulmonary embolism have been filed in association with UPADACITINIB (Rinvoq). This represents 0.6% of all adverse event reports for UPADACITINIB.
423
Reports of Pulmonary embolism with UPADACITINIB
0.6%
of all UPADACITINIB reports
28
Deaths
242
Hospitalizations
How Dangerous Is Pulmonary embolism From UPADACITINIB?
Of the 423 reports, 28 (6.6%) resulted in death, 242 (57.2%) required hospitalization, and 44 (10.4%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which UPADACITINIB Alternatives Have Lower Pulmonary embolism Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL